Committed to You
Type 2 Diabetes taking Insulin & Oral Medication

The DUAL™ II trial is an international diabetes research study which will investigate the safety and efficacy of the combination of a GLP-1 analogue (Victoza®) and basal insulin (insulin degludec) in controlling glycaemia.

The trial will involve almost 400 patients with type 2 diabetes in 7 countries worldwide.

Qualified participants will receive comprehensive care, including regular health checks and medical testing as well as access to trial medication and blood glucose testing equipment at no cost. Participants may also be compensated for time and travel to our office.

To join the trial you must be:
  • - 18 years of age or older
  • - Have Type 2 Diabetes
  • - Treated with basal insulin and 1-2 oral antidiabetic (metformin with or without sulfonylurea or glinides)
  • - Able to attend 11 clinic visits and 23 telephone contacts during the 29 weeks you participate in the trial.
  • - Other criteria will apply . . .

  • To receive more information about this study, please take a moment to complete our online survey or you may call us directly at 817-281-4156.

    Study volunteers are not required to complete this online survey in order to be considered for participation in this study. The purpose of this online survey is for us to collect your contact information as well as a brief medical history to help determine your eligibility.

    All information provided will be considered confidential and will not be shared outside of Protenium Clinical Research. For your protection, all patient health information may be destroyed at your request if you do not qualify for this study
    Name
    Phone Number
    Email
    Are you at least 18 years of age?


    Have you been diagnosed with Type 2 Diabetes Mellitus?


    Are you taking between 18 to 44 units of basal insulin (for example, insulin glargine, insulin detemir, or NPH insulin)?


    Are you also taking metformin with or without sulphonylurea or glinide?


    Please list any other medications you are taking, including any for conditions other than diabetes.
    How did you learn about us?









    Please select one of the two options regarding how Protenium Clinical Research should manage your information should you NOT qualify for this study.
    All patient health information is considered confidential and will not be shared outside of Protenium Clinical Research.